Fidelity SPDR Advertisement
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
Member Level 
Followed By 479
Posts 71,125
Boards Moderated 4
Alias Born 03/31/08
160x600 placeholder
U.S. Stocks: Futures Weaken After Data
U.S. stock futures pulled back on Wednesday after the first batch of economic data, slated to roll out Wednesday, came in softer than expected.
Top Equities Stories Of The Day
Spotify's Revenue Rose in 2013, But Losses Continued - 2nd Update
SEC Grants Bank of America Short-Term Waiver from Hedge-Fund Restrictions
Telefónica Works to Redraw Its Empire
Canada Resident Caught Up in China Corruption Probe
Appeals Court Grants TV Programmers Stay in FCC Dispute -- Update
Samsung to Buy Back $2 Billion Worth of Shares -- Update
Correction to La Compagnie Fares Story
Kinder Morgan Unveils $6 Billion Debt Offer -- Update
dDT Member Level  Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 81603 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist